- JP-listed companies
- LTT Bio-Pharma Co., Ltd.
- Income statement
LTT Bio-Pharma Co., Ltd.【JP:E00982】Income statement
Market cap
P/E ratio
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Revenue | 61 | 68 | 86 | 59 | 71 | 51 | 38 | 27 | 19 | 25 | 5 | 15 | 75 | 61 |
| Gross profit | - | - | - | 54 | 55 | 34 | 37 | 27 | 15 | 11 | 5 | 15 | 48 | 36 |
| Gross margin (%) | - | - | - | |||||||||||
| Operating expenses | - | - | - | 477 | 370 | 573 | 675 | 601 | 709 | 642 | 624 | 880 | 697 | 693 |
| Operating income | - | - | - | -422 | -315 | -538 | -639 | -574 | -694 | -630 | -619 | -865 | -649 | -657 |
| Income before tax | -65 | 147 | 149 | 1,808 | 333 | 1,818 | 1,497 | 395 | -729 | 271 | -222 | 81 | 555 | 1,421 |
| Provision for income taxes | - | - | - | 225 | 65 | 409 | 369 | 65 | 78 | 88 | 40 | 9 | 201 | 286 |
| Net income | -66 | 116 | 104 | 1,583 | 264 | 1,408 | 1,126 | 327 | -807 | 181 | -263 | 70 | 299 | 1,085 |
| Earnings per share | -503.28 | 881.58 | 791.45 | 12,006.61 | 2,005 | 10,678.48 | 8,539.6 | 2,480.74 | -6,121.32 | 1,375.6 | -1,998.2 | 532.76 | 2,270.54 | 8,225.66 |
| Dividend per share | - | - | - | 2,000 | - | 2,000 | 2,000 | - | 2,000 | - | - | 1,000 | - | - |